aminocaproic acid has been researched along with B16 Melanoma in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirstein, JM | 1 |
| Graham, KC | 1 |
| Mackenzie, LT | 1 |
| Johnston, DE | 1 |
| Martin, LJ | 1 |
| Tuck, AB | 1 |
| MacDonald, IC | 1 |
| Chambers, AF | 1 |
| Perides, G | 1 |
| Zhuge, Y | 1 |
| Lin, T | 1 |
| Stins, MF | 1 |
| Bronson, RT | 1 |
| Wu, JK | 1 |
2 other studies available for aminocaproic acid and B16 Melanoma
| Article | Year |
|---|---|
Effect of anti-fibrinolytic therapy on experimental melanoma metastasis.
Topics: Aminocaproic Acid; Animals; Aprotinin; Cell Line, Tumor; Female; Hemostatics; Lung Neoplasms; Melano | 2009 |
The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis.
Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Ca | 2006 |